Hematopoietic stem cell engraftment and interaction with bone marrow niche and immune compartments

Hematopoietic stem cell (HSC) engraftment is a complex, multi-step biological process where transplanted or endogenous stem cells migrate to and settle within the bone marrow microenvironment (Lapidot et al., 2005, Blood). This process is heavily dependent on the "niche," a specialized environment consisting of osteoblasts, endothelial cells, and mesenchymal stromal cells that provide essential survival and self-renewal signals (Scadden, 2006, Nature). The interaction is primarily mediated by the CXCR4/CXCL12 (SDF-1) signaling axis, which acts as a chemoattractant for HSCs, alongside various adhesion molecules like VLA-4 and selectins (Liesveld et al., 2020, Bone Marrow Transplantation). Immune compartments, including regulatory T cells and macrophages, further influence this niche by maintaining an "immune-privileged" site or facilitating HSC mobilization (Fujisaki et al., 2011, Nature). Dysregulation of these interactions is a hallmark of hematologic diseases such as leukemia, where the niche can protect malignant cells from chemotherapy (Lane et al., 2014, Nature Reviews Cancer). Therapeutic strategies often involve modulating these interactions; for example, the CXCR4 antagonist Plerixafor is used to mobilize HSCs into the peripheral blood for collection (DiPersio et al., 2009, Blood). Understanding the interplay between HSCs, the niche, and the immune system is critical for improving outcomes in hematopoietic stem cell transplantation and developing regenerative medicine therapies.

Other names

Hematopoietic stem cell engraftmentHSC-niche interactionHematopoietic stem cell homingBone marrow niche interaction

CXCR4 antagonism to disrupt the CXCL12/CXCR4 retention axis; G-CSF receptor agonism to induce protease-mediated niche remodeling; VLA-4 inhibition to block cell-to-cell adhesion.